| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Electron transport chain oxphos system in mitochondria 0.6385835883855409 3.42157377105537 0.0006225983217336 0.3143665223849626 0.1580780275284306 51 P14927,P51970,Q16718,P21912,P36542,Q9Y6M9,P14406,O75964,P10606,O43676,P03886,P20674,O43674,O75306,O75380,O14949,P56385,P05141,O96000,P15954,Q9Y6N1,P56556,Q9UDW1,O95168 24 |
| Nonalcoholic fatty liver disease 0.6049469375090409 3.1934660941737167 0.0014057584483233 0.5736475626152978 0.1580780275284306 53 P14927,P51970,Q16718,P21912,Q9Y6M9,P14406,P10606,O43676,P20674,O43674,O75306,O75380,O14949,P54646,Q9P0J0,Q86Y39,P63000,O96000,P15954,P60953,P56556,Q9UDW1,O95168 23 |
| Proteasome degradation 0.6175622862666539 2.919665514997097 0.0035040726171453 0.8808291513969665 0.1769556671658407 42 P46934,P01889,P49721,P60900,P28074,P28072,P28070 7 |
| Mitochondrial complex i assembly model oxphos system 0.6792280422109185 2.868851574903275 0.0041196506933518 0.918051547566726 0.178322022869373 31 Q96CU9,O43674,O43676,Q7L592,P03886,P51970,Q16718,O75306,Q8N183,O75489,O75380,O96000,Q9Y6M9,Q9P0J0,Q9BU61,P56556,O95168,Q9Y375 18 |
| Mitochondrial complex iv assembly 0.7898159925371794 2.3846130572731647 0.0170970936999623 0.9999710642166408 0.4144335512870879 11 P10606,Q96I36,Q9Y2R0,P20674,P14406,P15954,Q9Y6N1 7 |
| Sphingolipid metabolism in senescence 0.7105361750508823 2.1357680722382217 0.0326983227490207 0.999999998219524 0.592979032248574 13 Q96G23,P11802,Q06136,P16278 4 |
| Sphingolipid metabolism integrated pathway 0.7309203076997862 2.1169963516429853 0.0342601574302345 0.9999999993312708 0.592979032248574 11 Q9NRA0,Q06136,Q96G23,Q8N5B7,O95470 5 |
| Fatty acid betaoxidation 0.6332638995854636 2.0851907279215385 0.0370519912108382 0.9999999998843032 0.592979032248574 19 O43772,P23786 2 |
| Mitochondrial long chain fatty acid betaoxidation 0.6957258603405733 2.064095873884355 0.0390086271120717 0.9999999999662704 0.592979032248574 13 O43772,P23786 2 |
| Oxidative phosphorylation 0.5509978610405375 2.0311625707987555 0.0422385058797454 0.9999999999956152 0.592979032248574 31 Q16795,P51970,Q16718,Q9Y6M9,O43678,O75947,O75964,O95182,P19404,P03886,O75489,O43674,O75306,O75380,P56385,Q86Y39,O00483,O96000,P56556,O95168 20 |
| Sphingolipid pathway 0.7021108644461957 1.983079142664684 0.0473585899731543 0.9999999999998296 0.592979032248574 11 Q96G23,O95470,Q8N5B7,Q06136 4 |
| Metabolism of spingolipids in er and golgi apparatus 0.8845618543164652 1.9686057265069348 0.0489983844725276 0.99999999999994 0.592979032248574 5 Q9NRA0,O95470,Q06136 3 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8796986450051225 1.9500653692834415 0.051168328213377 0.999999999999985 0.592979032248574 5 Q14739 1 |
| Ketogenesis and ketolysis 0.8781839333098129 1.9442840872589555 0.0518612024903868 0.9999999999999905 0.592979032248574 5 P53985,O43772 2 |
| Sphingolipid metabolism overview 0.6946000142640358 1.897885991263212 0.0577111021374134 0.9999999999999998 0.6340387306205366 10 Q96G23,Q9NRA0,O95470,Q06136 4 |
| Mitochondrial complex iii assembly 0.6924990397824081 1.8881793976523695 0.0590018706754142 1.0 0.6340387306205366 10 P14927,O14949,Q9Y276,Q9UDW1 4 |
| Transcriptional activation by nrf2 in response to phytochemicals 0.8622983478239402 1.883465534603875 0.059637306345496 1.0 0.6340387306205366 5 P09601 1 |
| Overview of nanoparticle effects 0.9820073095305032 1.8646477717098555 0.0622307920424884 1.0 0.6372602861554613 2 Q6P4R8 1 |
| Atm signaling in development and disease 0.5548703566321047 1.858520902820094 0.0630950778371743 1.0 0.6372602861554613 25 Q14739,P78527 2 |
| Familial partial lipodystrophy fpld 0.7137649446722389 1.8366804789595137 0.0662570787217093 1.0 0.6476095113767079 8 O75844 1 |
| Adipogenesis 0.5947012430590813 1.7950441086876874 0.0726466725608121 1.0 0.6785983912016986 17 O75844,P43490 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7894735585069717 1.732188197929589 0.0832400596779334 1.0 0.7168167334193425 6 P09601,P07099 2 |
| Eicosanoid metabolism via lipooxygenases lox 0.7880944826106413 1.726718329310439 0.0842182621845657 1.0 0.7168167334193425 6 Q15067,Q14914 2 |
| Disruption of postsynaptic signaling by cnv 0.6699505168251252 1.7106748774136995 0.0871411478786785 1.0 0.7168167334193425 9 P27361,Q13555,Q06787,Q12959,Q7L576 5 |
| Influence of laminopathies on wnt signaling 0.6383538835595585 1.6800849334798276 0.0929407918630489 1.0 0.7230024488324903 11 O60725,O75844,P48729 3 |
| Nuclear receptors metapathway 0.43051583015605 1.66112183651039 0.0966889796680876 1.0 0.7230024488324903 50 P09601,P23786,Q99735,Q8IWT6,Q15067,P11802,O00767,Q9HCL2,P08183,Q14914 10 |
| Vitamin d receptor pathway 0.5779675591200775 1.5805216632444687 0.1139874498097406 1.0 0.761714171184999 15 Q92604,Q8IWT6,P08183 3 |
| Mitochondrial immune response to sarscov2 0.6398261054310956 1.5716615800878189 0.1160290568279731 1.0 0.761714171184999 9 Q9Y276,Q9Y6M9,Q7Z434 3 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.606483898359665 1.571233083680908 0.1161285180314064 1.0 0.761714171184999 12 Q32P28,Q96AY3 2 |
| Ovarian infertility 0.9027270171492792 1.544121543966859 0.1225588906019257 1.0 0.7817967126817577 2 P11802 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4952548820066028 1.4978884845122935 0.1341622260447199 1.0 0.7954972518118033 26 O76062,Q14739,O00767,Q9UBM7,P48449 5 |
| Dna irdouble strand breaks and cellular response via atm 0.4904256788094492 1.4896853055375836 0.1363070001081388 1.0 0.7954972518118033 27 Q9UQ84,P78527 2 |
| Circadian rhythm genes 0.4175488740136638 1.4867781958958146 0.1370734020953246 1.0 0.7954972518118033 46 P04818,P29375,P78527,P11802,Q9BWF3,P43490,Q8WXF1,O14744,Q86U44 9 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.549546210255437 1.483889068401795 0.1378383524208879 1.0 0.7954972518118033 16 P11802,O60725,O75844 3 |
| Mthfr deficiency 0.721302539287414 1.4591778247504836 0.1445161705345707 1.0 0.7961527213086353 6 P35790,P21964 2 |
| Riboflavin and coq disorders 0.7192376197380226 1.4508373006882884 0.1468251703095495 1.0 0.7962406463142987 6 Q86YH6,Q16134 2 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.6692838008584587 1.4340031064721388 0.1515713763588198 1.0 0.7987152528125634 7 P09601 1 |
| Eicosanoid synthesis 0.8689907225189732 1.406984181136523 0.1594320795530093 1.0 0.807190946132586 2 P09960 1 |
| Nuclear receptors in lipid metabolism and toxicity 0.8664605004216955 1.3967000544146078 0.162503787835273 1.0 0.807190946132586 2 P08183 1 |
| Ectoderm differentiation 0.4930879800654605 1.3841086631877135 0.1663251846577544 1.0 0.8194557878260098 22 Q12923,P42356,P16278 3 |
| Envelope proteins and their potential roles in edmd physiopathology 0.5100525039781907 1.3795969253095577 0.1677107846654904 1.0 0.8196188347361869 19 Q14739 1 |
| Copper homeostasis 0.6058539159479751 1.3489177161986727 0.177363397100104 1.0 0.847115926028408 8 O75880,P98170,Q9Y6N1,P35670 4 |
| Eicosanoid metabolism via cyclooxygenases cox 0.686518442169767 1.318314566317885 0.1873983667753358 1.0 0.847115926028408 6 Q14914 1 |
| Histone modifications 0.5975097674203842 1.3106457676277723 0.1899774689778439 1.0 0.847115926028408 8 Q9H7B4 1 |
| 15q112 copy number variation syndrome 0.7141792938357381 1.30311029469011 0.1925371094899841 1.0 0.847115926028408 5 Q06787,Q7L576 2 |
| Kennedy pathway from sphingolipids 0.6818969494965579 1.2995551684878488 0.1937534735570054 1.0 0.847115926028408 6 P35790,O95470 2 |
| Triacylglyceride synthesis 0.804017907775793 1.2982349561782842 0.1942066095786789 1.0 0.847115926028408 4 Q9HCL2 1 |
| Nonhomologous end joining 0.6779178295855582 1.283398476034832 0.1993525075286188 1.0 0.847115926028408 6 P78527 1 |
| Nephrotic syndrome 0.5371665495555632 1.265663645565524 0.2056335291572781 1.0 0.847115926028408 13 O75844,Q14108 2 |
| Estrogen receptor pathway 0.8675888926656437 1.233950341444327 0.2172214090767992 1.0 0.8603671496767341 3 Q9HCL2 1 |
| Aspirin and mirnas 0.8192296879392678 1.2052473701486996 0.2281078203598316 1.0 0.87677704235186 2 Q15118 1 |
| Vitamin a and carotenoid metabolism 0.6889797085284627 1.2030770338502157 0.2289465117783895 1.0 0.87677704235186 5 Q8WTV0,P29375 2 |
| Alzheimers disease 0.3558880954224654 1.1647919058853398 0.2441032360345323 1.0 0.8788806511373942 88 P49721,P48729,P28070,P28074,P28072,P60900 6 |
| Pparalpha pathway 0.6065741469409613 1.163898753462735 0.2444650448318674 1.0 0.8788806511373942 7 P11802 1 |
| Omega9 fatty acid synthesis 0.6472314986445958 1.1587682127872816 0.2465506777118102 1.0 0.8788806511373942 6 O00767,O95864 2 |
| Alzheimers disease and mirna effects 0.3515576565821014 1.1176097222932186 0.2637337146319027 1.0 0.8911713651498955 89 P20618,P49721,P48729,P28070,P28074,P28072,P60900 7 |
| Nrf2are regulation 0.5352103459505955 1.081509344894241 0.2794706061022141 1.0 0.8911713651498955 9 P09601,P48506 2 |
| Dna mismatch repair 0.4538997501770306 1.0761821224060637 0.2818458135399009 1.0 0.8911713651498955 20 Q9NR33,Q9UQ84 2 |
| Progeriaassociated lipodystrophy 0.5061874739354719 1.0666452775169424 0.2861320465289059 1.0 0.8911713651498955 12 O75844 1 |
| Cholesterol biosynthesis pathway 0.4879346420256764 1.0517343614483734 0.2929214413276049 1.0 0.8911713651498955 14 P04035,Q14534,P53602,P37268,Q9UBM7,P48449 6 |
| Wnt signaling 0.4708932580334888 1.048710847538458 0.2943112201701512 1.0 0.8911713651498955 16 Q13555,P67870,P48729,Q8TAA9 4 |
| Translation factors 0.3939841832112771 1.0318441864073364 0.3021451158954025 1.0 0.8911713651498955 37 O75153 1 |
| 7oxoc and 7betahc pathways 0.5112059273558085 1.0256545529945296 0.3050544434398152 1.0 0.8911713651498955 10 Q9UBM7,O15118 2 |
| Omega3 omega6 fatty acid synthesis 0.6135850586765202 1.0225385308515114 0.3065260858128877 1.0 0.8911713651498955 6 Q15067,O95864 2 |
| Prostaglandin and leukotriene metabolism in senescence 0.7169185375679736 0.9735709286589584 0.3302696267034015 1.0 0.8984382200852523 4 P09960 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3884077700741536 0.9554302567376212 0.3393601591297055 1.0 0.9013826295793635 35 P04035,P55735,P54646,P37268,O00767,Q9HCL2,P48449,Q8WTV0,Q12770 9 |
| Nocgmppkg mediated neuroprotection 0.5527915388581437 0.9332527788240808 0.3506894699327119 1.0 0.908195806748818 7 Q13555,Q15334 2 |
| Ferroptosis 0.4037762261047912 0.9060162952827648 0.3649272274923065 1.0 0.9097714885821956 27 P09601,P04035,P37268,Q96QD8,P48506 5 |
| Type ii interferon signaling ifng 0.5427506554392545 0.8906866244254195 0.3730973124481727 1.0 0.9152426134684122 7 P01889,Q03518 2 |
| Fatty acid transporters 0.6043046360465079 0.8702331309192204 0.384173013677223 1.0 0.9152426134684122 5 Q9UKU0 1 |
| Cerebral organic acidurias including diseases 0.6015756893640808 0.8597037907234979 0.3899523446633002 1.0 0.9152426134684122 5 Q92947,P48735,P40926,P49419 4 |
| Allograft rejection 0.469737060663651 0.854776984677318 0.3926746219161148 1.0 0.9152426134684122 11 P08183 1 |
| Lung fibrosis 0.5686353199099371 0.8428809257975521 0.3992950422362293 1.0 0.9195472064793144 6 P09601 1 |
| T cell receptor and costimulatory signaling 0.5606843749039455 0.8115782823884012 0.4170336571555788 1.0 0.9291264567510322 6 P48729 1 |
| Dna damage response 0.3840404572078745 0.7622346326018501 0.4459199795576865 1.0 0.9473739965587654 26 P49959,Q8WXE1,P78527,P11802,P41440 5 |
| Tca cycle aka krebs or citric acid cycle 0.4201037145982551 0.7339280385525626 0.4629925974184234 1.0 0.9650437447930698 15 P21912 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.5038324601658621 0.728523041090108 0.4662934693904756 1.0 0.9677186385295488 7 Q9HB09,Q9BXK5,P23229 3 |
| Cytoplasmic ribosomal proteins 0.3153995166480025 0.7122848935214349 0.4762883766259551 1.0 0.98508790524003 76 P49207,P46779,P49406,P62854,Q02543,Q02878,P39023,Q07020,P23396,P46776,P47914,P18124,P62753,P62917,P62241,P46778,P83881,P61353,P50914,P36578,P62829,P62273,P40429,P18077,P05386,P63173,P46781,P62913,P83731,P62424 30 |
| Mirna regulation of dna damage response 0.3728899402583913 0.7021120522113068 0.4826092867483313 1.0 0.9880446884104352 27 P49959,Q8WXE1,P78527,P11802,P41440 5 |
| Cell cycle 0.3222866230452132 0.677155047205452 0.4983075858024413 1.0 1.0 55 Q9UBD5,Q9Y619,P78527,P11802,O43913,P30260 6 |
| Statin inhibition of cholesterol production 0.5252477648558519 0.6747392151835553 0.499841465082238 1.0 1.0 6 P04035,P37268,Q8WTV0 3 |
| Neuroinflammation and glutamatergic signaling 0.3765779355111118 0.6640727932539605 0.5066437223048827 1.0 1.0 22 Q8IWT6,Q96QD8 2 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.5218638759676906 0.6619502920055489 0.5080030790641206 1.0 1.0 6 P11802 1 |
| Camkk2 pathway 0.410365271279324 0.6516058096255681 0.5146554989568735 1.0 1.0 14 P09601,P63000,Q9Y3D6,P42345 4 |
| Onecarbon metabolism and related pathways 0.4078458871817492 0.6391290211968926 0.5227390018467211 1.0 1.0 14 P48506,P35790,P04818 3 |
| 1q211 copy number variation syndrome 0.430748246693569 0.6060743551351799 0.544465379368599 1.0 1.0 9 P54646,Q9NPH0 2 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.406179675856358 0.6026501363997845 0.5467414597086506 1.0 1.0 13 O00303 1 |
| Nrf2 pathway 0.3655378659668101 0.5790243221526609 0.5625727618982892 1.0 1.0 21 P09601,Q99735,Q14914 3 |
| Dna irdamage and cellular response via atr 0.3200339729203635 0.5584730090263559 0.5765214304231625 1.0 1.0 43 Q9UQ84,P78527 2 |
| Tumor suppressor activity of smarcb1 0.3845625666198899 0.5540220378458249 0.5795637636772448 1.0 1.0 15 P11802,O96019,Q969G3,Q12824 4 |
| Dna repair pathways full network 0.3051794792139522 0.5408264955110239 0.5886271786101589 1.0 1.0 60 Q13426,Q9UQ84,P78527,Q92759,Q9NR33 5 |
| Oxidative stress response 0.4884915748092981 0.5392313678499487 0.589727218805169 1.0 1.0 6 P09601 1 |
| Ppar signaling pathway 0.3632245008068205 0.5199025012294092 0.6031315319996042 1.0 1.0 18 P09110,O95573,Q9UKU0,Q15067,P50416,O00767,O14975,O95864,P23786 9 |
| Complement and coagulation cascades 0.6333989316839956 0.5047878105831977 0.6137078781154273 1.0 1.0 2 Q00610 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.4021754910079735 0.4868438964318956 0.6263689599007567 1.0 1.0 9 P31943,P61020,O14964 3 |
| Relationship between inflammation cox2 and egfr 0.5744674234952987 0.482057794967817 0.6297648903750082 1.0 1.0 4 Q9H7Z7 1 |
| Nucleotide excision repair 0.3341500312221149 0.4679937432108176 0.6397890640754689 1.0 1.0 28 Q13619,Q92759,Q9NR33,P41440,P15927 5 |
| Oxysterols derived from cholesterol 0.4048276684109027 0.4617969187933327 0.64422696069055 1.0 1.0 8 Q9UBM7 1 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3739421428297314 0.4540717732271482 0.6497771687526426 1.0 1.0 13 P27361,Q15334,P54646,P42345,P21359 5 |
| Insulin signaling in adipocytes normal condition 0.5636027176865482 0.448920776507866 0.6534888077515673 1.0 1.0 4 P42345 1 |
| Insulin signaling in adipocytes diabetic condition 0.5636027176865482 0.448920776507866 0.6534888077515673 1.0 1.0 4 P42345 1 |
| Vitamin dsensitive calcium signaling in depression 0.422976483866186 0.4183623207876503 0.6756822308732426 1.0 1.0 7 Q8NB78 1 |
| Hostpathogen interaction of human coronaviruses autophagy 0.4469520145458855 0.3977046243353139 0.690847928296733 1.0 1.0 6 Q99570,P42345,Q9NT62 3 |
| Gastric cancer network 1 0.3641882022676233 0.3720576148689916 0.7098499530056919 1.0 1.0 10 Q9NS87,Q96Q89,P62805 3 |
| Thermogenesis 0.3114745540072832 0.3604417590118359 0.718516803083133 1.0 1.0 31 O43772,P23786 2 |
| Hippo signaling regulation pathways 0.3295028746331782 0.346737848840543 0.7287882729096933 1.0 1.0 17 P63000,P54646,P60953,P42345,P10644 5 |
| Cohesin complex cornelia de lange syndrome 0.3277386877800327 0.3456063337675945 0.729638585323998 1.0 1.0 18 Q7Z5K2,Q96GD4 2 |
| Ebola virus infection in host 0.2920438072533483 0.3453545322446048 0.7298278547340793 1.0 1.0 43 P46934,P01889,O15118,P41440,P23229 5 |
| Fragile x syndrome 0.2820034523348723 0.3310218619527844 0.7406279721492901 1.0 1.0 49 Q15118,P53680,P53985,Q15334,Q9NZ01,Q06787,P10644,Q7L576 8 |
| Glycerolipids and glycerophospholipids 0.3620976343164706 0.3079062888562285 0.7581536403149369 1.0 1.0 8 Q9HBU6,Q9UG56,Q86UL3,Q9HCL2 4 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.334977958815053 0.2787023977375575 0.7804732222695394 1.0 1.0 12 Q9NR77,P20338 2 |
| Glucocorticoid receptor pathway 0.3399863981432637 0.2607543425343296 0.7942819559688676 1.0 1.0 9 Q8IWT6 1 |
| Male infertility 0.2984163409031434 0.2560817533170373 0.7978877110726461 1.0 1.0 23 Q13426,P08183 2 |
| Eukaryotic transcription initiation 0.305143082786694 0.2471127210288851 0.8048209890220741 1.0 1.0 18 Q92759 1 |
| Cell migration and invasion through p75ntr 0.365306654322902 0.2372037843833229 0.8124987005751396 1.0 1.0 7 Q8TEW0 1 |
| Serine metabolism 0.3916239374868742 0.2366550147012805 0.8129244366859447 1.0 1.0 6 P04818,P34896 2 |
| Aryl hydrocarbon receptor pathway wp2586 0.3169546459936302 0.2119252301514161 0.8321653668155882 1.0 1.0 10 P48506,O00170,P06400,P21359 4 |
| Praderwilli and angelman syndrome 0.3165546977014716 0.2107428955552945 0.8330879004015528 1.0 1.0 10 P11802 1 |
| Breast cancer pathway 0.2872965848446705 0.2035579394965191 0.838698964299925 1.0 1.0 26 P49959,P48729,P11802,P42345,P67870,P06400 6 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.3117351100262092 0.199004694966373 0.842259071997639 1.0 1.0 12 P48729 1 |
| Congenital generalized lipodystrophy cgl 0.5195389373067062 0.1982727943729593 0.8428316360745303 1.0 1.0 2 P31751 1 |
| Folate metabolism 0.2932034554526854 0.1830011809238755 0.8547970920225478 1.0 1.0 16 P41440,Q8WTV0 2 |
| Tp53 network 0.5001405678942777 0.1617824800701765 0.8714771501579306 1.0 1.0 2 P42771 1 |
| Transcription factor regulation in adipogenesis 0.4998594321056919 0.1612904353222838 0.8718646561404004 1.0 1.0 2 Q16822 1 |
| Nicotine effect on dopaminergic neurons 0.4430379746835531 0.156317101443047 0.8757830770372512 1.0 1.0 4 P63096,P62136,Q00535 3 |
| Il17 signaling pathway 0.3554742471151168 0.1532629410675262 0.8781909240953503 1.0 1.0 6 P27361,P49841,P40763,Q04206,Q9Y6K9 5 |
| 3q29 copy number variation syndrome 0.2901413453609462 0.1506896356565544 0.8802205494189319 1.0 1.0 14 P52298,O75592,Q12959 3 |
| Gaba metabolism aka ghb 0.5017874434214311 0.148423899299298 0.8820082400444278 1.0 1.0 3 O43488 1 |
| Inclusion body myositis 0.4873453318335315 0.1270944155217865 0.8988656713880645 1.0 1.0 3 Q92542,P05067 2 |
| Gaba receptor signaling 0.2948107699103856 0.1247811578336182 0.900696804661983 1.0 1.0 8 P53680 1 |
| Epo receptor signaling 0.3161666715172394 0.1223137110808133 0.9026505736587712 1.0 1.0 7 Q15118 1 |
| Kisspeptinkisspeptin receptor system in the ovary 0.3386127786881866 0.1210445977801275 0.903655710950749 1.0 1.0 6 Q15118 1 |
| Tryptophan metabolism 0.2814263035310212 0.1183252248791154 0.9058099712311458 1.0 1.0 13 Q16836,P40939,Q92947,P51648,P05091 5 |
| Biomarkers for pyrimidine metabolism disorders 0.3110756138248353 0.1127690722462424 0.9102136386705688 1.0 1.0 7 P04818 1 |
| Amyotrophic lateral sclerosis als 0.2792577176969766 0.1041274563613427 0.9170682022636664 1.0 1.0 9 Q9BUN8,P63000 2 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.4696287964004612 0.1040514905323891 0.9171284867597732 1.0 1.0 3 Q15758,Q14145 2 |
| G1 to s cell cycle control 0.2635615275033474 0.1020727291537381 0.9186989469156316 1.0 1.0 26 Q9Y619,P11802,O43913 3 |
| Modulators of tcr signaling and t cell activation 0.2727031480740187 0.1020081003275042 0.9187502454951376 1.0 1.0 14 O96000 1 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.2866342026360066 0.0732090378984403 0.9416397744861732 1.0 1.0 7 Q15118,Q15382,P42345 3 |
| Id signaling pathway 0.4352946552423711 0.0687598954513544 0.9451807412909708 1.0 1.0 3 P06400 1 |
| Rala downstream regulated genes 0.3035741179769275 0.0680085253735987 0.9457788477326204 1.0 1.0 6 P60953 1 |
| Cannabinoid receptor signaling 0.3031162718705925 0.0674374426046963 0.9462334621321108 1.0 1.0 6 P27361,P10644 2 |
| Energy metabolism 0.2591803062468995 0.0657349518313091 0.9475888450435364 1.0 1.0 13 Q13555 1 |
| Neovascularisation processes 0.4220391326991219 0.0582045079223007 0.9535857300092988 1.0 1.0 3 P27361 1 |
| Exrna mechanism of action and biogenesis 0.3659634317862202 0.0572586180137609 0.954339184282264 1.0 1.0 4 Q9UPY3,Q8WYQ5,Q9HAV4 3 |
| Ncrnas involved in stat3 signaling in hepatocellular carcinoma 0.4028675850435743 0.0504575605109352 0.9597577681050647 1.0 1.0 2 Q04206 1 |
| Airway smooth muscle cell contraction 0.300225098480599 0.0484814998977346 0.9613325080453978 1.0 1.0 5 P31150,P62140,O75116,Q13464 4 |
| Dna replication 0.2497335933631061 0.0475742133959755 0.9620555834814856 1.0 1.0 30 Q9Y619,P41440,O43913 3 |
| Burn wound healing 0.26524349629398 0.0468124327481506 0.962662719997658 1.0 1.0 7 P50454,P31949 2 |
| Thiamine metabolic pathways 0.2783563186039999 0.0409602764273319 0.9673275640863206 1.0 1.0 6 Q02218,P08559,P29401,Q9HC21,O14874 5 |
| Mirna biogenesis 0.3434599156118176 0.0407298896119177 0.9675112328957798 1.0 1.0 4 Q9UPY3,Q8WYQ5,Q9HAV4 3 |
| Retinoblastoma gene in cancer 0.2405331484136849 0.0397510252146148 0.9682916215590228 1.0 1.0 52 P11802,P78527 2 |
| Melanoma 0.2424393082689465 0.0388863916596911 0.9689809662458546 1.0 1.0 15 P27361,P63000,P06400,P11802 4 |
| Atr signaling 0.3312439211554869 0.0337024796069544 0.9731144016569312 1.0 1.0 4 Q8WXE1 1 |
| White fat cell differentiation 0.3773903262092303 0.0333017129403883 0.973433987789984 1.0 1.0 3 Q04726,P04150 2 |
| Interactions between loxl4 and oxidative stress pathway 0.3568616422947184 0.0263545918238035 0.978974512031988 1.0 1.0 3 Q96EB6,Q9BQ95 2 |
| Hair follicle development organogenesis part 2 of 3 0.3557367829021449 0.0260396929526125 0.9792256787770526 1.0 1.0 3 Q9BZE4,P05556 2 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.3551743532058529 0.0258845956052107 0.9793493868571556 1.0 1.0 3 P27361,P40763 2 |
| Synaptic vesicle pathway 0.2370022870077163 0.0255118218232383 0.9796467191057304 1.0 1.0 13 P53680,Q00610,P12235 3 |
| Nucleotide metabolism 0.2362559909782884 0.0237556768610777 0.9810474948026602 1.0 1.0 12 P23921,P19623,P00374,P31350,P30566,P30520,P13995,P00492,P28340,P20839,P09884 11 |
| Purinergic signaling 0.3032348804500771 0.0219418737639566 0.9824943223724892 1.0 1.0 4 P04899,P63096,P08754 3 |
| Nucleotide excision repair in xeroderma pigmentosum 0.241387027314353 0.0183867405909051 0.9853303301316862 1.0 1.0 37 Q13619,Q92759,Q9NR33,P41440,P15927,P62805 6 |
| Gdnfret signaling axis 0.3017435320584979 0.0168257024682841 0.9865756651932852 1.0 1.0 3 Q9BW83,P35222 2 |
| Homologous recombination 0.226914414414412 0.0163859553332007 0.9869264842670612 1.0 1.0 7 P27694,Q9Y2S7,O60934,P49959,P49005,P28340 6 |
| Ddx1 as a regulatory component of the drosha microprocessor 0.2267867191896563 0.0110704888659046 0.9911672082719204 1.0 1.0 5 Q92499,O60934,Q8WYQ5,P49959 4 |
| Cytosolic dnasensing pathway 0.2235944353560895 0.0108804006719602 0.991318867572087 1.0 1.0 17 P19388 1 |
| Fluoroacetic acid toxicity 0.2138682436892993 0.0085964409984836 0.9931411169267634 1.0 1.0 5 P51648 1 |
| Ccl18 signaling pathway 0.1900872993523016 0.0060426374789698 0.9951787021894029 1.0 1.0 8 P00403,P07196,P42224,P19022,P08670,Q86UE4,P00338 7 |
| Alpha 6 beta 4 signaling pathway 0.21914473256603 0.0022835173945434 0.9981780183100084 1.0 1.0 12 P63000,P42345,P23229 3 |
| Spinal cord injury 0.2253345383758702 0.0006240831313262 0.9995020537371806 1.0 1.0 21 P63000,P11802,P60953,P06400,P17931 5 |
|
|
